BIMEPRAZOL DIN 02531674
Health Canada record
| Active ingredient(s) | OMEPRAZOLE 37 % |
|---|---|
| Dosage form | Paste |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 08-Nov-2023 |
| Current status date | 08-Nov-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bimeda-MTC Animal Health Inc. — licence 100306, currently licensed, last inspection rating NC (2026-03-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OMEPRAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245058 | APO-OMEPRAZOLE | APOTEX INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 02250349 | GASTROGARD | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Paste | OMEPRAZOLE 37 % | Marketed |
| 02435683 | HEARTBURN CONTROL | APOTEX INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 00846503 | LOSEC | CHEPLAPHARM ARZNEIMITTEL GMBH | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 02339927 | OMEPRAZOLE | PRO DOC LIMITEE | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 02348691 | OMEPRAZOLE | SANIS HEALTH INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 02411857 | OMEPRAZOLE-20 | SIVEM PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Marketed |
| 02245059 | APO-OMEPRAZOLE | APOTEX INC | Capsule (Delayed-Release) | OMEPRAZOLE 40 MG | Cancelled Pre Market |
| 02422220 | AURO-OMEPRAZOLE | AURO PHARMA INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02422212 | AURO-OMEPRAZOLE | AURO PHARMA INC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Post Market |
| 02364352 | AVA-OMEPRAZOLE | AVANSTRA INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02119579 | LOSEC CAPSULES 10MG | ASTRAZENECA CANADA INC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Post Market |
| 02016788 | LOSEC CAPSULES 40MG | ASTRAZENECA CANADA INC | Capsule (Delayed-Release) | OMEPRAZOLE 40 MG | Cancelled Post Market |
| 02329425 | MYLAN-OMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Post Market |
| 02329433 | MYLAN-OMEPRAZOLE | MYLAN PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02438968 | OMEP | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02385376 | OMEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Pre Market |
| 02385384 | OMEPRAZOLE | SIVEM PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02320851 | PMS-OMEPRAZOLE | PHARMASCIENCE INC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02320843 | PMS-OMEPRAZOLE | PHARMASCIENCE INC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Pre Market |
| 02372258 | Q-OMEPRAZOLE | QD PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Pre Market |
| 02372274 | Q-OMEPRAZOLE | QD PHARMACEUTICALS ULC | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02403617 | RAN-OMEPRAZOLE | RANBAXY PHARMACEUTICALS CANADA INC. | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
| 02296438 | SANDOZ OMEPRAZOLE | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | OMEPRAZOLE 10 MG | Cancelled Post Market |
| 02296446 | SANDOZ OMEPRAZOLE | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | OMEPRAZOLE 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29164 | 2022-10-11 | Abbreviated New Drug Submission (ANDS) |
International API supply for OMEPRAZOLE
20 valid EDQM Certificates of Suitability from 20 holders. 115 active FDA Drug Master Files.
Request a quote for BIMEPRAZOL